- Home
- GIFT vs KZR Comparison
GIFT vs KZR Comparison
Compare GIFT & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIFT
- KZR
- Stock Information
- Founded
- GIFT 1999
- KZR 2015
- Country
- GIFT United States
- KZR United States
- Employees
- GIFT N/A
- KZR N/A
- Industry
- GIFT Catalog/Specialty Distribution
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- GIFT Consumer Discretionary
- KZR Health Care
- Exchange
- GIFT Nasdaq
- KZR Nasdaq
- Market Cap
- GIFT 55.1M
- KZR 44.1M
- IPO Year
- GIFT N/A
- KZR 2018
- Fundamental
- Price
- GIFT $2.05
- KZR $6.10
- Analyst Decision
- GIFT Strong Buy
- KZR Hold
- Analyst Count
- GIFT 1
- KZR 2
- Target Price
- GIFT $4.00
- KZR $9.00
- AVG Volume (30 Days)
- GIFT 124.6K
- KZR 31.1K
- Earning Date
- GIFT 03-18-2025
- KZR 03-17-2025
- Dividend Yield
- GIFT N/A
- KZR N/A
- EPS Growth
- GIFT N/A
- KZR N/A
- EPS
- GIFT N/A
- KZR N/A
- Revenue
- GIFT $86,439,146.00
- KZR N/A
- Revenue This Year
- GIFT $3.23
- KZR N/A
- Revenue Next Year
- GIFT $25.39
- KZR N/A
- P/E Ratio
- GIFT N/A
- KZR N/A
- Revenue Growth
- GIFT N/A
- KZR N/A
- 52 Week Low
- GIFT $0.50
- KZR $5.20
- 52 Week High
- GIFT $4.27
- KZR $10.40
- Technical
- Relative Strength Index (RSI)
- GIFT N/A
- KZR 50.24
- Support Level
- GIFT N/A
- KZR $5.51
- Resistance Level
- GIFT N/A
- KZR $6.29
- Average True Range (ATR)
- GIFT 0.00
- KZR 0.32
- MACD
- GIFT 0.00
- KZR 0.02
- Stochastic Oscillator
- GIFT 0.00
- KZR 55.66
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.